Premium
GIRFT01: Money matters: assessing the value of the adalimumab biosimilar switch plan for dermatology patients
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19962
Subject(s) - biosimilar , adalimumab , medicine , dermatology , value for money , value (mathematics) , computer science , economics , machine learning , public economics , disease